ABL Bio
Korea - Seongnam
BiotechnologyFocus: Antibody, Immuno-oncology
ABL Bio is a life sciences company focused on Antibody, Immuno-oncology.
Oncology
Open Jobs
0
Pipeline & Clinical Trials
ABL103
Advanced Solid TumorClinical Trials (1)
NCT06126666A Study With ABL103 in Subjects With Advanced or Metastatic Solid Tumors
Phase 1ABL501
Advanced Solid TumorClinical Trials (1)
NCT05101109Study to Evaluate the Safety and Tolerability of ABL501, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL501 in Subjects With Any Progressive, Locally Advanced (Unresectable) or Metastatic Solid Tumors
Phase 1NOV1501
Advanced Solid TumorsClinical Trials (1)
NCT03292783This is a Study to Evaluate the Safety and Tolerability of the Study Drug ABL001, and to Determine the Maximum Tolerated Dose and/or Recommended Phase 2 Study Dose of ABL001
Phase 1ABL301
HealthyClinical Trials (1)
NCT05756920This is a Study to Evaluate the Safety, Tolerability, PK and PD of IV Administered ABL301 in Healthy Adult Participants
Phase 1ABL503
Advanced Solid TumorClinical Trials (1)
NCT04762641This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors
Phase 1ABL103
Solid TumorsCTX-009
P1b: Advanced Solid TumorsClinical Trials (1)
NCT04492033A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients
Phase 1/2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2020
Portfolio: 6 clinical trials